X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Comm & Energy
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Election 2016
    • Polling Explorer
    • Just In
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Rio 2016
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
UPDATE 1-US court rules again against vaccine-autism claims
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Bonds News | Fri Mar 12, 2010 5:47pm EST

UPDATE 1-US court rules again against vaccine-autism claims

* Ruling is the fourth against autism claims

* Court says mercury preservative did not cause autism (Adds reaction)

By Maggie Fox, Health and Science Editor

WASHINGTON, March 12 Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court ruled on Friday, dealing one more blow to parents seeking to blame vaccines for their children's illness.

The special U.S. Court of Federal Claims ruled that vaccines could not have caused the autism of an Oregon boy, William Mead, ending his family's quest for reimbursement.

"The Meads believe that thimerosal-containing vaccines caused William's regressive autism. As explained below, the undersigned finds that the Meads have not presented a scientifically sound theory," Special Master George Hastings, a former tax claims expert at the Department of Justice, wrote in his ruling.

In February 2009, the court ruled against three families who claimed vaccines caused their children's autism, saying they had been "misled by physicians who are guilty, in my view, of gross medical misjudgment".

The families sought payment under the National Vaccine Injury Compensation Program, a no-fault system that has a $2.5 billion fund built up from a 75-cent-per-dose tax on vaccines.

Instead of judges, three "special masters" heard the three test cases representing thousands of other petitioners.

They asked whether a combination vaccine for measles, mumps and rubella, or MMR, plus a mercury-containing preservative called thimerosal, caused the children's symptoms.

MYSTERIOUS CONDITION

More than 5,300 cases were filed by parents who believed vaccines may have caused autism in their children. The no-fault payout system is meant to protect vaccine makers from costly lawsuits that drove many out of the vaccine-making business.

Autism is a mysterious condition that affects as many as one in 110 U.S. children. The so-called spectrum ranges from mild Asperger's Syndrome to severe mental retardation and social disability, and there is no cure or good treatment.

The U.S. Institute of Medicine has reported several times that no link can be found between vaccines and autism.

Supporters of the scientific community welcomed the ruling.

"It's time to move forward and look for the real causes of autism," said Alison Singer, president of the Autism Science Foundation. "There is not a bottomless pit of money with which to fund autism science. We have to use our scarce resources wisely."

But advocates for the idea that vaccines are dangerous said they would not give up. "We hope that Congress will intervene in what is clearly a miscarriage of justice to vaccine-injured children," said Jim Moody of the Coalition for Vaccine Safety.

Autism Speaks, another advocacy group, said it would also not completely abandon the theory that vaccines might cause autism.

The organization said it would invest "in research to determine whether subsets of individuals might be at increased risk for developing autism symptoms following vaccination."

But the group also said it was clear that if such a link did exist, it would be rare.

"While we have great empathy for all parents of children with autism, it is important to keep in mind that, given the present state of the science, the proven benefits of vaccinating a child to protect them against serious diseases far outweigh the hypothesized risk that vaccinations might cause autism," Autism Speaks said in a statement.

(Editing by Philip Barbara)

Trending Stories

    Editor's Pick

    LIVE: Election 2016

    Sponsored Topics

    Next In Bonds News

    CANADA FX DEBT-C$ strengthens to 7-week high against weaker greenback

    * Canadian dollar at C$1.2859, or 77.77 U.S. cents * Bond prices mixed across the maturity curve TORONTO, Aug 16 The Canadian dollar strengthened to a seven-week high against its broadly weaker U.S. counterpart on Tuesday as oil rose and domestic data showed a rebound in factory sales. Canadian factory sales increased 0.8 percent in June from May as sales of machinery and transportation equipment grew, according to Statistics Canada data. Economists had expected a 0.7 pe

    BRIEF-Cavium enters into a credit agreement

    * Credit agreement provides for a $700.0 million six-year term B loan facility

    BRIEF-Perk.com says buys out of earn-out obligations with Orion Foundry

    * Perk Inc announces buyout of earn-out obligations under asset purchase agreement with Orion Foundry (Canada) Inc

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy